Indaptus Therapeutics, Inc. - Common Stock (INDP)
CUSIP: 45339J105
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 111,087,302
- Total 13F shares
- 579,339
- Share change
- -41,500
- Total reported value
- $1,079,449
- Price per share
- $1.85
- Number of holders
- 15
- Value change
- -$60,057
- Number of buys
- 5
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45339J105:
Top shareholders of INDP - Indaptus Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Hoonmo Lee |
3/4/5
|
Director |
—
mixed-class rows
|
708,272
mixed-class rows
|
$1,626,157 | — | 04 Aug 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.23%
|
250,348
|
$363,005 | — | 31 Dec 2022 | |
| INVESTMENT HOUSE LLC |
13F
|
Company |
0.09%
|
95,629
|
$138,662 | — | 31 Dec 2022 | |
| STRATEGY ASSET MANAGERS LLC |
13F
|
Company |
0.05%
|
55,336
|
$80,000 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
50,521
|
$72,000 | — | 31 Dec 2022 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.02%
|
26,832
|
$38,906 | — | 31 Dec 2022 | |
| Vivaldi Capital Management LP |
13F
|
Company |
0.02%
|
24,000
|
$38,400 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
19,473
|
$28,041 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
19,100
|
$28,000 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
14,495
|
$20,873 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
12,898
|
$18,702 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,742
|
$10,000 | — | 31 Dec 2022 | |
| Boyan Vesselinov Litchev |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
1,150
|
$2,691 | — | 01 Feb 2022 | |
| Bangor Savings Bank |
13F
|
Company |
0%
|
400
|
$1,000 | — | 31 Dec 2022 | |
| Brian O'Callaghan |
3/4/5
|
Director |
—
class O/S missing
|
13,750
|
$976 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
529
|
$767 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
98
|
$142 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
11
|
$16 | — | 31 Dec 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
7
|
$10 | — | 31 Dec 2022 |
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock (INDP) as of Q1 2023
As of 31 Mar 2023,
Indaptus Therapeutics, Inc. - Common Stock (INDP) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
579,339 shares.
The largest 10 holders included
VANGUARD GROUP INC, INVESTMENT HOUSE LLC, STRATEGY ASSET MANAGERS LLC, GEODE CAPITAL MANAGEMENT, LLC, Pine Valley Investments Ltd Liability Co, Vivaldi Capital Management LP, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and Tower Research Capital LLC (TRC).
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
16
Q1 2023 holders
15
Holder diff
-1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.